RxDoctor Payments DataLook up a doctor →

Rajiv Agarwal

Nephrology · Indianapolis, INNPI 1154386258

Payments from drug & device makers

$1,217,870in general payments, 2019–2025

Across 569 payments — averaging $2140.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$344K
  • Vertex$268K
  • Alnylam Pharmaceuticals Inc.$176K
  • Akebia Therapeutics Inc$79K
  • Boehringer Ingelheim International GmbH$67K
  • Vifor Pharma, Inc.$62K
  • plus $223K from 12 others
$294,674in research payments, 2019–2025

Across 89 payments — averaging $3310.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bayer$160K
  • Intercept Pharmaceuticals, Inc.$110K
  • Novartis$25K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,217,870 in reported general payments places this provider in the 95th percentile of 238 nephrology providers in Indiana.

See all nephrology providers in Indiana

Other nephrology in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →